DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous10.06.2021 / 21:23 The issuer is solely responsible for the content of this announcement.NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIB.
RNS Number : 1286X
29 April 2021
Synlab AG Stabilisation Notice in accordance with Articles 6(1) and 8 of Commission Delegated Regulation (EU) 2016/1052 29 April 2021 Goldman Sachs Bank Europe SE (contact: Philipp Suess; telephone: +69 7532 1267) hereby gives notice that the entity undertaking stabilisation (the Stabilisation Manager named below and its affiliates) may stabilise the offer of the following securities in accordance with Article 5(4) and (5) of Regulation (EU) No 596/2014 (Market Abuse Regulation) and Articles 5 through 8 of Commission Delegated Regulation (EU) 2016/1052. Stabilisation transactions aim at supporting the market price of the Securities during the Stabilisation Period. However, the Stabilisation Manager is under no obligation to take any stabilisation measures. Therefore, Stabilisation may not necessarily occur and it may cease at any time.